Edition:
United States

Progenics Pharmaceuticals Inc (PGNX.OQ)

PGNX.OQ on NASDAQ Stock Exchange Global Select Market

6.01USD
22 Jul 2016
Change (% chg)

$-0.15 (-2.44%)
Prev Close
$6.16
Open
$6.21
Day's High
$6.24
Day's Low
$5.97
Volume
453,045
Avg. Vol
325,676
52-wk High
$11.15
52-wk Low
$3.64

Select another date:

Tue, Jul 19 2016

BRIEF-Valeant and Progenics announce FDA approvals for relistor

* Valeant expects to commence sales of relistor tablets in U.S. in Q3 of 2016

BRIEF-Progenics Pharmaceuticals signs commercial license agreement with Selexis SA

* Under agreement, progenics will have use of Selexis CHO-M cell line and sure technology platform

BRIEF-Progenics Pharma Q1 loss per share $0.18

* Progenics pharmaceuticals announces first quarter 2016 financial and business results

BRIEF-Progenics Pharma, Valeant say FDA extended Relistor PDUFA to July 19

* Valeant and Progenics announce pdufa date extension for oral relistor

Select another date: